ð ã2024-2025ãä»ã·ãŒãºã³ã®æè¡çã®ç¹åŸŽ
2024-2025幎ã·ãŒãºã³ã¯ãCOVID-19ã®åœ±é¿ãèœã¡çãäžæ¹ã§ãã€ã³ãã«ãšã³ã¶ãåŒåžåšææçã®å¢å ã«ããæè¡çã®çºçãã¿ãŒã³ã«å€åãèŠãããŠããŸãã
åçåŽåçã®ææ°ããŒã¿ïŒ2024幎12æçºè¡šïŒã«ãããšãä»ã·ãŒãºã³ã®ç¹åŸŽãšããŠä»¥äžã®ç¹ãæããããŸãïŒ
- é«éœ¢è æœèšã§ã®ã¯ã©ã¹ã¿ãŒææã«äŒŽãæè¡ççäŸã®å¢å
- ãã¹ã¯ççšç¿æ £ã®ç·©åã«ãããèºççèææçãå幎æ¯çŽ20%å¢å
- å ç«åäœäžã«ããæ¥åèŠææããã®æè¡çãæ£èŠããã
- æ©æèšºææè¡ã®åäžã«ãããè»œçæ®µéã§ã®çºèŠçãæ¹å
ç¹ã«æ³šæãå¿ èŠãªã®ã¯ãææå¯Ÿçã®ç·©åã«äŒŽããåŸæ¥ã®ææçãã¿ãŒã³ãæ»ãã€ã€ããããšã§ãããããŸã§ä»¥äžã«åºæ¬çãªææäºé²çã®éèŠæ§ãé«ãŸã£ãŠããŸãã
ã€ã³ãã«ãšã³ã¶ã®ææå¯Ÿçã«ã€ããŠã¯ãã€ã³ãã«ãšã³ã¶ã®åºåžåæ¢ã¯ãã€ãŸã§ïŒåŸ©åž°ã®å€æåºæºãšæ³šæç¹ã®èšäºã§è©³ãã解説ããŠããŸãã®ã§ã䜵ããŠãåç §ãã ããã
ð¥ ã¯ããã«
颚éªãæªæã«ããææçã¯ãç§ãã¡ã«ãšã£ãŠèº«è¿ãªå¥åº·åé¡ã§ãããããããããã®ææçãé©åã«æ²»çãããªãå Žåããå ç«åãäœäžããŠããç¶æ ã§ã¯ããæè¡çããšããåœã«é¢ããå±éºãªç¶æ ã«é²è¡ããããšããããŸãã
æè¡çã¯ãææçã«å¯Ÿãã身äœã®éå°ãªå ç«åå¿ã«ãã£ãŠãå šèº«ã®èåšæ©èœãé害ãããé節ãªç æ ã§ãããã€ãŠã¯ãè¡æ¶²ã®æåããšããæå³ã§äœ¿ãããŠããŸããããçŸåšã§ã¯ææçã«ããå šèº«æ§ã®ççåå¿çå矀ãšããŠçè§£ãããŠããŸãã
æ¥æ¬åœå ã§ã¯å¹ŽéçŽ37äžäººãæè¡çãçºçãããã®ãã¡çŽ10äžäººãåœãèœãšããŠãããšãããŠããŸããããã¯äº€éäºæ ã«ããæ»äº¡è æ°ã®çŽ30åã«ãããæ°åã§ãããæ±ºããŠçšãªç æ°ã§ã¯ãããŸãããæ©æçºèŠãšè¿ éãªæ²»çéå§ãçæ»ãåããçŸæ£ã ãããããæ£ããç¥èãæã€ããšãéèŠã§ãã
æ¬èšäºã§ã¯ãæè¡çã®åºç€ç¥èããææ°ã®æ²»çæ³ãŸã§ãäžè¬ã®æ¹ã«ããããããã詳ãã解説ããŠãããŸãã
ð¬ æè¡çãšã¯äœã
ð æè¡çã®å®çŸ©
æè¡ç(ã¯ããã€ããããè±èª:Sepsis)ãšã¯ã现èããŠã€ã«ã¹ãªã©ã®åŸ®çç©ã«ããææçã«å¯ŸããŠã身äœã®å ç«ã·ã¹ãã ãéå°ã«åå¿ããããšã§ãèªåèªèº«ã®çµç¹ãèåšã«ãã¡ãŒãžãäžããŠããŸãç¶æ ãæããŸãã
2016幎ã«åœéçãªå°éå®¶ã°ã«ãŒãã«ãã£ãŠçºè¡šããããSepsis-3ããšããæ°ããå®çŸ©ã§ã¯ãæè¡çã¯ãææçã«å¯Ÿããå¶åŸ¡äžèœãªå®¿äž»åå¿ã«èµ·å ããçåœãè ããèåšé害ããšå®çŸ©ãããŠããŸãã
ã€ãŸããåãªãææçã§ã¯ãªããææçã«ãã£ãŠåŒãèµ·ããããå šèº«æ§ã®ççåå¿ããå¿èãèºãè èãèèãªã©ã®éèŠãªèåšã®æ©èœãäœäžãããŠããŸãç¶æ ãªã®ã§ãã
ð æè¡çãšé¢é£ããçšèª
æè¡çãçè§£ããäžã§ãããã€ãã®é¢é£çšèªãç¥ã£ãŠããããšãéèŠã§ãã
å šèº«æ§ççåå¿çå矀(SIRS)
ææçã«éãããå€å·ãç±å·ãªã©ã«ãã£ãŠãåŒãèµ·ããããå šèº«æ§ã®ççåå¿ã®ããšã§ãã以äžã®4é ç®ã®ãã¡2é ç®ä»¥äžãæºããå Žåã«SIRSãšèšºæãããŸãã
- äœæž©:38â以äžãŸãã¯36â以äž
- å¿ææ°:90å/å以äž
- åŒåžæ°:20å/å以äžããŸãã¯PaCO2 32mmHg以äž
- çœè¡çæ°:12,000/ÎŒL以äžã4,000/ÎŒL以äžããŸãã¯æªççœè¡ç10%以äž
æè¡çæ§ã·ã§ãã¯
æè¡çã®äžã§ãç¹ã«éçãªç¶æ ã§ãè¡å§ãèããäœäžããååãªèŒžæ¶²ãè¡ã£ãŠãæ£åžžãªè¡å§ãç¶æã§ããªãç¶æ ã§ããæ»äº¡çã¯40%以äžãšéåžžã«é«ããç·æ¥ã®éäžæ²»çãå¿ èŠãšãªããŸãã
å€èåšäžå š(MOF)
æè¡çãé²è¡ãããšãè€æ°ã®èåšãåæã«æ©èœäžå šã«é¥ãç¶æ ã§ããäžè¬çã«2ã€ä»¥äžã®èåšç³»çµ±ãé害ãããå ŽåãæããŸãã
ð æè¡çã®éç床åé¡
çŸåšãæè¡çã®éç床ã¯äž»ã«ãqSOFA(quick SOFA)ã¹ã³ã¢ããšãSOFAã¹ã³ã¢ããšãã2ã€ã®è©äŸ¡ã·ã¹ãã ã§å€å®ãããŸãã
qSOFAã¹ã³ã¢(ç°¡æç)
ææ¥å€æ¥ãäžè¬ç æ£ã§è¿ éã«è©äŸ¡ã§ããææšã§ã以äžã®3é ç®ãè©äŸ¡ããŸãã
- åŒåžæ°:22å/å以äž
- æèã¬ãã«:GCS(ã°ã©ã¹ãŽãŒã»ã³ãã»ã¹ã±ãŒã«)13ç¹ä»¥äž
- åçž®æè¡å§:100mmHg以äž
ãããã®ãã¡2é ç®ä»¥äžè©²åœããå Žåãæè¡çã®å¯èœæ§ãé«ããéäžæ²»çãå¿ èŠãšãªãå¯èœæ§ããããŸãã
SOFAã¹ã³ã¢
åŒåžãååºãèèã埪ç°ãäžæ¢ç¥çµãè èã®6ã€ã®èåšç³»çµ±ãè©äŸ¡ããããããã0~4ç¹ã§ã¹ã³ã¢åããŸããææçã«ãã£ãŠSOFAã¹ã³ã¢ã2ç¹ä»¥äžäžæããå Žåãæè¡çãšèšºæãããŸãã
ðŠ æè¡çã®åå
ð¥ ææçã®çš®é¡
æè¡çã¯æ§ã ãªææçããçºçããå¯èœæ§ããããŸããäž»ãªåå ãšãªãææçãéšäœå¥ã«èŠãŠãããŸãããã
èºç(æãå€ãåå )
æè¡çã®åå ãšããŠæãå€ãã®ãèºçã§ããç¹ã«é«éœ¢è ãå ç«åãäœäžããŠããæ¹ã§ã¯ãèºçããæè¡çã«é²è¡ãããªã¹ã¯ãé«ãŸããŸããèºççèãã€ã³ãã«ãšã³ã¶èãé»è²ãããŠçèãªã©ã®çްèãäž»ãªåå èãšãªããŸãã
å°¿è·¯ææç
è çè çãè€éæ§å°¿è·¯ææçãæè¡çã®éèŠãªåå ã§ããç¹ã«é«éœ¢è ã§ã¯å°¿è·¯ææçãåå ã§æè¡çãçºçããã±ãŒã¹ãå€ãèŠãããŸããå€§è žèãæãå€ãããã®ä»ã¯ã¬ãã·ãšã©ãç·è¿èãªã©ãåå ãšãªããŸãã
è ¹è å ææç
è«åç(ç²è ž)ãèå¢çãæ©å®€çãè ¹èçãªã©ã®è ¹è å ã®ææçãæè¡çã®åå ãšãªããŸããè ¹è å ã«ã¯å€æ§ãªçްèãååšããããããã°ãã°è€æ°ã®èã«ããæ··åææãšãªããŸãã
ç®èã»è»éšçµç¹ææç
è窩ç¹çã壿»æ§çèçã耥ç¡(åºãã)ã®ææãªã©ãåå ãšãªãããšããããŸããç¹ã«ç³å°¿ç æ£è ã§ã¯ãè¶³ã®æœ°çããæè¡çã«è³ãã±ãŒã¹ãèŠãããŸãã
ç®èææçã«ã€ããŠã¯ãç²ç€ãææãããæçç©è³ªã§æ²»ãïŒæææã®æ²»çæ³ãšåçºäºé²ã解説ã®èšäºã§è©³ãã解説ããŠããŸãã®ã§ã䜵ããŠãåç §ãã ããã
ã«ããŒãã«é¢é£è¡æµææç
äžå¿éèã«ããŒãã«ãæ«æ¢¢éèã«ããŒãã«ãªã©ã®å»çåšå ·ãä»ããææãéèŠãªåå ã§ããé»è²ãããŠçèãã«ã³ãžããªã©ãäž»ãªåå èãšãªããŸãã
ð¬ åå 埮çç©
æè¡çãåŒãèµ·ãã埮çç©ã¯å€å²ã«ããããŸãã
现è
- ã°ã©ã éœæ§è:é»è²ãããŠçèãã¬ã³ãµçèãèºççèãªã©
- ã°ã©ã é°æ§è:å€§è žèãã¯ã¬ãã·ãšã©ãç·è¿èãã¢ã·ãããã¯ã¿ãŒãªã©
- 嫿°æ§è:ãã¯ããã€ãã¹ãã¯ãã¹ããªãžãŠã ãªã©
çè
ã«ã³ãžããã¢ã¹ãã«ã®ã«ã¹ãªã©ã®çèããç¹ã«å ç«åãèããäœäžããæ£è ã§ã¯æè¡çã®åå ãšãªããŸãã
ãŠã€ã«ã¹
ã€ã³ãã«ãšã³ã¶ãŠã€ã«ã¹ãCOVID-19(æ°åã³ãããŠã€ã«ã¹)ããµã€ãã¡ã¬ããŠã€ã«ã¹ãªã©ããéçåãããšæè¡çæ§ã®ç¶æ ãåŒãèµ·ããããšããããŸãã
â ïž ãªã¹ã¯èŠå
以äžã®ãããªæ¡ä»¶ã«è©²åœããæ¹ã¯ãæè¡çãçºçãããããšãããŠããŸãã
幎霢
- 65æ³ä»¥äžã®é«éœ¢è
- 1æ³æªæºã®ä¹³å
å 霢ã«äŒŽãå ç«æ©èœã®äœäžããä¹³å ã®æªçãªå ç«ã·ã¹ãã ãåå ãšãªããŸãã
åºç€çŸæ£
- ç³å°¿ç
- æ ¢æ§è èç
- è硬å€
- æªæ§è «ç(ãã)
- æ ¢æ§é塿§èºçŸæ£(COPD)
- å¿äžå š
- HIVææç
ãããã®çŸæ£ã¯å ç«æ©èœãäœäžããããããææçãéçåãããããªããŸãã
å ç«æå¶ç¶æ
- ã¹ããã€ãè¬ãå ç«æå¶è¬ã®é·æäœ¿çš
- æãã倿²»çäž
- èåšç§»æ€åŸ
- èŸèæåºåŸ
å»çè¡çºã«é¢é£ããèŠå
- é·æå ¥é¢
- éäžæ²»ç宀ã§ã®æ²»ç
- 人工åŒåžåšã®äœ¿çš
- äžå¿éèã«ããŒãã«ã®ç眮
- å°¿éã«ããŒãã«ã®é·æç眮
- æè¡çŽåŸ
çæŽ»ç¿æ £
- é床ã®é£²é
- å«ç
- æ é€äžè¯
âïž æè¡çã®ç æ ã¡ã«ããºã
ð¥ ççåå¿ã®æŽèµ°
éåžžãç§ãã¡ã®èº«äœã¯çްèããŠã€ã«ã¹ãªã©ã®ç åäœãäŸµå ¥ãããšãå ç«ã·ã¹ãã ãæŽ»æ§åããŠççåå¿ãèµ·ãããŸãããã®ççåå¿ã¯ãç åäœãæé€ããæå·ããçµç¹ã修埩ããããã®æ£åžžãªé²åŸ¡æ©æ§ã§ãã
ããããæè¡çã§ã¯ããã®ççåå¿ãå¶åŸ¡äžèœãšãªããéå°ã«æŽ»æ§åããŠããŸããŸããå ·äœçã«ã¯ä»¥äžã®ãããªçŸè±¡ãèµ·ãããŸãã
ãµã€ãã«ã€ã³ã¹ããŒã
å ç«çްèãã倧éã®ãµã€ãã«ã€ã³(ççæ§ç©è³ª)ãæŸåºãããå šèº«ã«åºãããŸããç¹ã«TNF-αãIL-1ãIL-6ãªã©ã®ççæ§ãµã€ãã«ã€ã³ãéå°ã«ç£çãããããšã§ãæ£åžžãªçµç¹ã«ãŸã§ãã¡ãŒãžãäžããŠããŸããŸãã
è¡ç®¡ééæ§ã®äº¢é²
éå°ãªççåå¿ã«ããè¡ç®¡ã®å£ãç·©ã¿ãè¡æ¶²äžã®æ°Žåãè¡ç®¡å€ã«æŒãåºããŸããããã«ããè¡å§ãäœäžããèåšãžã®è¡æµãæžå°ããŸãã
埮å°åŸªç°é害
å šèº«ã®çްãè¡ç®¡(æ¯çްè¡ç®¡)ã§è¡æµãæ»ããçµç¹ãžã®é žçŽ äŸçµŠãäžè¶³ããŸãããŸããè¡æ¶²ãåºãŸãããããªã(æç𮿧è¡ç®¡å ååº:DIC)ãããã«è¡æµéå®³ãæªåããŸãã
ð« èåšé害ã®é²è¡
è¡æµé害ãšççæ§ç©è³ªã«ããã以äžã®ãããªèåšé害ãé²è¡ããŸãã
埪ç°åšç³»
å¿èã®åçž®åãäœäžããè¡ç®¡ãæ¡åŒµããããšã§è¡å§ãèããäœäžããŸã(æè¡çæ§ã·ã§ãã¯)ãååãªèŒžæ¶²ãè¡ã£ãŠãè¡å§ãç¶æã§ããªããªããæå§è¬ã®æäžãå¿ èŠãšãªããŸãã
åŒåžåšç³»
èºã®ççã«ãããæ¥æ§åŒåžçª®è¿«çå矀(ARDS)ãçºçããããšããããŸããèºèãé害ãããé žçŽ ãè¡æ¶²äžã«åã蟌ãããšãå°é£ã«ãªããŸãã人工åŒåžåšã«ãã管çãå¿ èŠãšãªãå ŽåããããŸãã
è è
è¡æµäœäžã«ããè èã®æ©èœãé害ãããæ¥æ§è é害ãçºçããŸããå°¿éãæžå°ããèå»ç©ãäœå ã«èç©ããŸããéçäŸã§ã¯éææ²»çãå¿ èŠãšãªããŸãã
èè
è现èãé害ãããèæ©èœãäœäžããŸããé»çžãåºçŸããããè¡æ¶²ååºå åã®ç£çãäœäžãããããŸãã
äžæ¢ç¥çµç³»
è³ãžã®è¡æµäœäžãççæ§ç©è³ªã®åœ±é¿ã«ãããæèã¬ãã«ãäœäžããŸããããåŠ(æèã®æ··ä¹±)ãæç¡ç¶æ ã«è³ãããšããããŸãã
æ¶ååšç³»
è žç®¡ã®è¡æµäœäžã«ãããè žç®¡ç²èã®ããªã¢æ©èœãç Žç¶»ããŸããããã«ããè žå 现èãè¡æ¶²äžã«äŸµå ¥ãããããªããææçãããã«æªåããæªåŸªç°ãçããŸãã
ð¡ïž æè¡çã®çç¶
ðš åæçç¶
æè¡çã®åææ®µéã§ã¯ã以äžã®ãããªçç¶ãèŠãããŸãã
çºç±ãŸãã¯äœäœæž©
38â以äžã®é«ç±ããŸãã¯éã«36â以äžã®äœäœæž©ãèŠãããŸããé«éœ¢è ã§ã¯çºç±ãç®ç«ããªãå Žåããããæ³šæãå¿ èŠã§ãã
é »è
å¿ææ°ã90å/å以äžã«å¢å ããŸããå®éã«ããŠããŠãåæžãæããããšããããŸãã
é »åŒåž
åŒåžåæ°ãå¢å ããæ¯èŠãããæããŸããåŒåžæ°ã22å/å以äžã«ãªããšãéçåã®ãµã€ã³ãšãªããŸãã
æªå¯ã»æŠæ
æ¿ãã坿°ããµããã䌎ãããšããããŸããäœæãæ¯åžããããŠãæž©ãŸããªããããªå¯æ°ãç¹åŸŽçã§ãã
å šèº«åŠæ æ
匷ãç²åŽæãè±åæããããèµ·ãäžããããšãå°é£ã«ãªããŸãã
â ïž é²è¡ããçç¶
æè¡çãé²è¡ãããšã以äžã®ãããªé節ãªçç¶ãçŸããŸãã
æèé害
ãŒããããšããŠåå¿ãéããªããæ¥æãå ŽæãããããªããªããäŒè©±ããã¿åããªããåŒã³ããã«åå¿ããªããªã©ã®çç¶ãèŠãããŸãã
è¡å§äœäž
åçž®æè¡å§ã100mmHg以äžã«äœäžããŸããããã«é²è¡ãããšã茞液ãè¡ã£ãŠãè¡å§ãç¶æã§ããªãæè¡çæ§ã·ã§ãã¯ã«è³ããŸãã
å°¿éæžå°
è èã®æ©èœäœäžã«ãããå°¿ã®éãèããæžå°ããŸã(0.5mL/kg/æä»¥äž)ã
ç®èã®å€å
- ç®èãå·ããæ¹¿ã£ãœããªã
- ç®èãéçœããªãããŸãã¯ãŸã ãã«ãªã
- 玫æ(ç®äžåºè¡)ãåºçŸãã
åŒåžå°é£
æ¯åããæ¿ãããªããæšªã«ãªã£ãŠããããªããªããŸããé žçŽ é£œå床ãäœäžããŸãã
èåšé害ã®çç¶
- é»çž(èé害)
- è ¹çãäžç¢(æ¶å管é害)
- åºè¡åŸå(ååºé害)
ðŽ é«éœ¢è ã®ç¹åŸŽçãªçç¶
é«éœ¢è ã§ã¯å žåçãªçç¶ãèŠãããªãããšããããæ³šæãå¿ èŠã§ãã
- çºç±ãç®ç«ããªãããŸãã¯äœäœæž©
- 飿¬²äžæ¯ãæŽ»åæ§ã®äœäž
- 転åãããããªã
- æ¥ãªèªç¥æ©èœã®äœäž
- ããåŠ(æèã®æ··ä¹±)
ãããã®éç¹ç°çãªçç¶ããæè¡çã®åæãµã€ã³ã§ããå¯èœæ§ããããŸãã
ð æè¡çã®èšºæ
ð 蚺æã®æµã
æè¡çãçãããå Žåãéããã«ä»¥äžã®ãããªèšºæããã»ã¹ãé²ããããŸãã
å蚺ãšèº«äœèšºå¯
å»åž«ã¯æ£è ã®çç¶ãæ¢åŸæŽãæè¿ã®ææçã®æç¡ãªã©ã詳ããèãåããŸãããŸãããã€ã¿ã«ãµã€ã³(äœæž©ãèæãè¡å§ãåŒåžæ°ãé žçŽ é£œå床)ãæž¬å®ããå šèº«ç¶æ ãè©äŸ¡ããŸãã
ææå·£ã®ç¹å®
æè¡çã®åå ãšãªã£ãŠããææçã®å Žæãç¹å®ããããšãéèŠã§ããèºçãå°¿è·¯ææçãè ¹è å ææçãªã©ãã©ãã«ææã®çŠç¹ããããã蚺å¯ãç»åæ€æ»ã§èª¿ã¹ãŸãã
ð§ª æ€æ»é ç®
è¡æ¶²æ€æ»
æè¡çã®èšºæãšéç床è©äŸ¡ã®ããã«ã以äžã®è¡æ¶²æ€æ»ãè¡ãããŸãã
- çœè¡çæ°:å¢å ãŸãã¯èããæžå°
- CRP(Cåå¿æ§èçœ):ççã®ææšãšããŠäžæ
- ããã«ã«ã·ããã³:çŽ°èææã§ç¹ç°çã«äžæããææš
- è¡å°æ¿æ°:æžå°(DICã®ææš)
- ååºæ©èœæ€æ»:PTãAPTTããã£ããªãã²ã³ãDãã€ããŒãªã©
- èæ©èœ:ASTãALTãããªã«ãã³ã®äžæ
- è æ©èœ:ã¯ã¬ã¢ããã³ãBUNã®äžæ
- é»è§£è³ª:ãããªãŠã ãã«ãªãŠã ãã«ã«ã·ãŠã ãªã©
- è¡ç³å€:é«è¡ç³ãŸãã¯äœè¡ç³
- ä¹³é žå€:çµç¹ã®é žçŽ äžè¶³ã®ææšãšããŠäžæ
- åèè¡æ¶²ã¬ã¹åæ:é žå¡©åºå¹³è¡¡ãé žçŽ åã®è©äŸ¡
è¡æ¶²å¹é€æ€æ»
è¡æ¶²äžã«çްèãã«ã³ãžããååšãããã調ã¹ãæãéèŠãªæ€æ»ã§ããéåžžãç°ãªãéšäœãã2ã»ããä»¥äžæ¡åããŸããçµæã倿ãããŸã§ã«2~5æ¥ããããŸãããåå èã®ç¹å®ãšé©åãªæèè¬ã®éžæã«äžå¯æ¬ ã§ãã
ãã®ä»ã®å¹é€æ€æ»
ææãçãããéšäœããæ€äœãæ¡åããå¹é€æ€æ»ãè¡ããŸãã
- åç°å¹é€(èºçã®å Žå)
- å°¿å¹é€(å°¿è·¯ææçã®å Žå)
- åµéšå¹é€(ç®èææçã®å Žå)
- è ¹æ°Žå¹é€(è ¹è å ææçã®å Žå)
ç»åæ€æ»
ææå·£ã®ç¹å®ãšèåšé害ã®è©äŸ¡ã®ããã«ã以äžã®ç»åæ€æ»ãè¡ãããŸãã
- èžéšXç·æ€æ»:èºçã®æç¡ã確èª
- è ¹éšè¶ 鳿³¢æ€æ»:èå¢çãè ¹è å è¿çã®è©äŸ¡
- CTæ€æ»:è©³çŽ°ãªææå·£ã®è©äŸ¡ãèåšé害ã®ç¢ºèª
- å¿ãšã³ãŒæ€æ»:å¿æ©èœã®è©äŸ¡ãå¿å èçã®é€å€
ð éç床è©äŸ¡
åè¿°ã®qSOFAã¹ã³ã¢ãSOFAã¹ã³ã¢ãçšããŠãæè¡çã®éç床ãè©äŸ¡ããŸããããã«ãããéäžæ²»çã®å¿ èŠæ§ãäºåŸã®äºæž¬ãå¯èœãšãªããŸãã
ð æè¡çã®æ²»ç
æè¡çã®æ²»çã¯ãæéãšã®æŠããã§ããçºçãã1æé以å ã«é©åãªæ²»çãéå§ããããšããçåçã倧ããå·Šå³ããŸãã
â° åæèç(æåã®1æé)
ãã³ãã«ã¢ãããŒã
æè¡çã®åææ²»çã§ã¯ããHour-1 BundleããšåŒã°ãã以äžã®æ²»çã1æé以å ã«éå§ããããšãæšå¥šãããŠããŸãã
- è¡æ¶²å¹é€æ¡å(æèè¬æäžå)
- ä¹³é žå€ã®æž¬å®
- åºåæèè¬ã®æäž
- äœè¡å§ãŸãã¯ä¹³é žå€4mmol/L以äžã®å Žåã30mL/kgã®æ¥é茞液
- 茞液åŸãäœè¡å§ãæç¶ããå Žåãæå§è¬ã®äœ¿çš
èŒžæ¶²çæ³
è¡ç®¡å ã®æ°Žåãè¡ç®¡å€ã«æŒãåºãã埪ç°è¡æ¶²éãæžå°ããŠããããã倧éã®èŒžæ¶²ãå¿ èŠãšãªããŸããåæã«ã¯æ¶è³ªæ¶²(ççé£å¡©æ°Žãä¹³é žãªã³ã²ã«æ¶²)ãçšããæ¥é茞液ãè¡ãããŸãã
ãã ããéå°ãªèŒžæ¶²ã¯èºæ°Žè «ãªã©ã®å䜵çãåŒãèµ·ãããããå¿æ©èœãèºã®ç¶æ ãã¢ãã¿ãªã³ã°ããªããæ éã«è¡ããŸãã
ð æèè¬çæ³
çµéšçæ²»ç
è¡æ¶²å¹é€ã®çµæã倿ããåã«ãäºæ³ãããåå èã«å¯ŸããŠæå¹ãªæèè¬ãæäžããŸããææéšäœãæ£è èæ¯ãèæ ®ããåºåã¹ãã¯ãã©ã ã®æèè¬ãéžæããŸãã
äžè¬çã«äœ¿çšãããæèè¬ã®çµã¿åãã:
- ã«ã«ãããã ç³»æèè¬(ã¡ãããã ãã€ãããã ãªã©)
- åºåããã·ãªã³ç³»+βã©ã¯ã¿ããŒãŒé»å®³è¬(ã¿ãŸãã¯ã¿ã ã»ããã©ã·ãªã³ãªã©)
- 第3äžä»£ãŸãã¯ç¬¬4äžä»£ã»ãã§ã ç³»æèè¬
MRSA(ã¡ãã·ãªã³èæ§é»è²ãããŠçè)ãçãããå Žåã¯ããã³ã³ãã€ã·ã³ããªããŸãªããªã©ã远å ããŸãã
æšçæ²»ç
è¡æ¶²å¹é€ãåçš®å¹é€æ€æ»ã®çµæã倿ããããåå èã«å¯ŸããŠããé©åãªæèè¬ã«å€æŽããŸã(de-escalation)ãããã«ããå¯äœçšãæžãããèæ§èã®åºçŸãé²ãããšãã§ããŸãã
â€ïž 埪ç°ç®¡ç
æå§è¬ã®äœ¿çš
ååãªèŒžæ¶²ãè¡ã£ãŠãè¡å§ãç¶æã§ããªãå Žåãæå§è¬ã䜿çšããŸãã
- ãã«ã¢ãã¬ããªã³(ãã«ãšããããªã³):第äžéžæè¬
- ããœãã¬ã·ã³:远å è¬ãšããŠäœ¿çš
- ãããã³ãã¢ãã¬ããªã³:ç¶æ³ã«å¿ããŠäœ¿çš
埪ç°ã¢ãã¿ãªã³ã°
äžå¿éèã«ããŒãã«ãåèã«ããŒãã«ãç眮ããè¡å§ãå¿æ©èœãæç¶çã«ã¢ãã¿ãªã³ã°ããŸããå Žåã«ãã£ãŠã¯å¿ãšã³ãŒãPiCCOãªã©ã®é«åºŠãªã¢ãã¿ãªã³ã°æ©åšã䜿çšããŸãã
ð« åŒåžç®¡ç
é žçŽ çæ³
äœé žçŽ è¡çã«å¯ŸããŠãé žçŽ æäžãè¡ããŸãã錻ã«ãã¥ãŒã¬ãé žçŽ ãã¹ã¯ããªã¶ãŒããŒãã¹ã¯ãªã©ãæ£è ã®ç¶æ ã«å¿ããŠæäžæ¹æ³ãéžæããŸãã
人工åŒåžåšç®¡ç
éçã®åŒåžäžå šã§ã¯ãæ°ç®¡æ¿ç®¡ãè¡ã人工åŒåžåšã«ãã管çãå¿ èŠãšãªããŸããARDSãå䜵ããŠããå Žåã¯ãäœäžåææ°éæŠç¥(èºä¿è·ææ°)ãæšå¥šãããŸãã
ð¥ è£å©çæ³
è¡ç³ã³ã³ãããŒã«
æè¡çã§ã¯è¡ç³å€ãå€åãããããªããŸããé«è¡ç³ã¯äºåŸãæªåããããããã€ã³ã¹ãªã³ã䜿çšããŠè¡ç³å€ã110~180mg/dLçšåºŠã«ç¶æããŸãã
æ é€ç®¡ç
æ©æã«çµè žæ é€(è管ãªã©ããæ é€å€ãæäž)ãéå§ããããšãæšå¥šãããŸããæ¶åç®¡ã®æ©èœãç¶æããå ç«æ©èœã®äœäžãé²ã广ããããŸãã
茞è¡çæ³
éçè²§è¡ãããå Žåã¯èµ€è¡ç茞è¡ãè¡ããŸããDICã«ããè¡å°æ¿æžå°ãååºå åã®äœäžã«å¯ŸããŠã¯ãè¡å°æ¿èŒžè¡ãæ°é®®åçµè¡æŒ¿ã®æäžãæ€èšãããŸãã
è 代æ¿çæ³(éæ)
æ¥æ§è é害ã«ããè æ©èœãèããäœäžããå Žåãæç¶çè 代æ¿çæ³(CRRT)ãè¡æ¶²éæãå¿ èŠãšãªããŸãã
ã¹ããã€ãçæ³
æè¡çæ§ã·ã§ãã¯ã§æå§è¬ã«åå¿ããªãå Žåãäœçšéãããã³ã«ããŸã³ã®æäžãæ€èšãããããšããããŸãã
ðª æææºã®ã³ã³ãããŒã«
å€ç§çä»å ¥
æææºãè¿ç(è¿ã®ããŸã)ã壿»çµç¹ãªã©ã®å Žåãå€ç§çã«ãã¬ããŒãž(æè¿)ããããªããã³(壿»çµç¹ã®é€å»)ãå¿ èŠãšãªããŸãã
äŸ:
- è ¹è å è¿çã®ãã¬ããŒãž
- 壿»æ§çèçã®ãããªããã³
- ææããç眮ã«ããŒãã«ã®æå»
- èå¢çã«å¯Ÿããè墿åºè¡
ãããã®åŠçœ®ã¯ãå¯èœãªéãæ©æã«(çæ³çã«ã¯12æé以å ã«)è¡ãããšãæšå¥šãããŠããŸãã
ð¥ éäžæ²»ç宀ã§ã®ç®¡ç
éçæè¡çãæè¡çæ§ã·ã§ãã¯ã®æ£è ã¯ãéäžæ²»ç宀(ICU)ã§ã®ç®¡çãå¿ èŠãšãªããŸãã24æéäœå¶ã§å»åž«ãçè·åž«ãç£èŠããç¶æ ã®å€åã«è¿ éã«å¯Ÿå¿ããŸãã
ICUã§ã¯ä»¥äžã®ãããªã¢ãã¿ãªã³ã°ãšæ²»çãè¡ãããŸã:
- æç¶çãªè¡å§ãå¿ææ°ãé žçŽ é£œå床ã®ã¢ãã¿ãªã³ã°
- å°¿éã®æ£ç¢ºãªæž¬å®
- 宿çãªè¡æ¶²æ€æ»ã«ããèåšæ©èœã®è©äŸ¡
- 人工åŒåžåšãè¡æ¶²æµåè£ çœ®ãªã©ã®çåœç¶æè£ 眮ã®äœ¿çš
- 耥ç¡äºé²ãæ é€ç®¡çãªã©ã®å šèº«ç®¡ç
ð æè¡çã®äºåŸãšå䜵ç
ð æ»äº¡ç
æè¡çã®æ»äº¡çã¯éç床ã«ãã£ãŠå€§ããç°ãªããŸãã
- æè¡ç:10~20%
- éçæè¡ç:20~40%
- æè¡çæ§ã·ã§ãã¯:40~60%
æ©æçºèŠãšé©åãªæ²»çã«ãããçåçãæ¹åã§ããããšã瀺ãããŠããŸããç¹ã«ãçç¶åºçŸãã1æé以å ã®æèè¬æäžãçåçåäžã®éµãšãªããŸãã
â¡ çæçå䜵ç
å€èåšäžå š
è€æ°ã®èåšãåæã«æ©èœäžå šã«é¥ãç¶æ ã§ãæè¡çã®æãé節ãªå䜵çã§ããé害ãããèåšã®æ°ãå€ãã»ã©ãæ»äº¡çãé«ããªããŸãã
æç𮿧è¡ç®¡å ååºçå矀(DIC)
å šèº«ã®è¡ç®¡å ã§è¡æ¶²ãååºããåæã«åºè¡åŸåãçããé節ãªç¶æ ã§ãã玫æãèåšåºè¡ãèåšæ¢å¡ãªã©ãåŒãèµ·ãããŸãã
æ¥æ§åŒåžçª®è¿«çå矀(ARDS)
èºã®ççã«ããåŒåžäžå šãé²è¡ããç¶æ ã§ã人工åŒåžåšã«ããé·æç®¡çãå¿ èŠãšãªãããšããããŸãã
æ¥æ§è é害
è æ©èœã®æ¥æ¿ãªäœäžã«ãããéæãå¿ èŠãšãªãå ŽåããããŸããå€ãã®å Žåãè æ©èœã¯å埩ããŸãããäžéšã®æ£è ã§ã¯æ ¢æ§è èç ãžç§»è¡ããããšããããŸãã
ð é·æçåŸéºç
æè¡çããå埩ããåŸãã以äžã®ãããªé·æçãªå¥åº·åé¡ãæ±ããæ£è ãå°ãªããããŸããããããã¯ãPost-Sepsis Syndrome(æè¡çåŸçå矀)ããšåŒã°ããŠããŸãã
身äœçåŸéºç
- æ ¢æ§ç²åŽ:極床ã®ç²ãããããæ°ã¶æ~æ°å¹Žç¶ã
- çåäœäž:é·æè¥åºãçèã®ç°å亢é²ã«ããçåãäœäžãã
- é¢ç¯çãçèçã®æç¶
- åŒåžæ©èœã®äœäž
- æ ¢æ§è èç
- å¿æ©èœã®äœäž
èªç¥æ©èœé害
- èšæ¶åã®äœäž
- éäžåã®äœäž
- 倿åã®äœäž
- èªç¥çã®ãªã¹ã¯å¢å
ç ç©¶ã«ãããšãæè¡çã®æ¢åŸãããé«éœ¢è ã¯ãããã§ãªãé«éœ¢è ã«æ¯ã¹ãŠèªç¥çã®çºçãªã¹ã¯ãçŽ3åé«ãããšãå ±åãããŠããŸãã
粟ç¥çåŸéºç
- PTSD(å¿çå€å·åŸã¹ãã¬ã¹é害):éäžæ²»ç宀ã§ã®äœéšããã©ãŠããšãªã
- ãã€ç :æè¡çåŸã«ãã€çç¶ãåºçŸããæ£è ãçŽ30%ååšãã
- äžå®é害
åçºãªã¹ã¯
æè¡çãçµéšããæ£è ã¯ããã®åŸãææçã«ãããããããåã³æè¡çãçºçãããªã¹ã¯ãé«ããªããŸãã1幎以å ã®åå ¥é¢çã¯çŽ40%ãšå ±åãããŠããŸãã
ðââïž ãªãããªããŒã·ã§ã³
æè¡çåŸã®å埩ã«ã¯ãé©åãªãªãããªããŒã·ã§ã³ãéèŠã§ãã
- æ©æé¢åº:å¯èœãªéãæ©ãåºäžããé¢ãã座äœãç«äœã®ç·Žç¿ãéå§
- çåŠçæ³:çåãã¬ãŒãã³ã°ãæ©è¡ç·Žç¿ãªã©
- äœæ¥çæ³:æ¥åžžç掻åäœã®ååŸ©æ¯æŽ
- èšèªèŽèŠçæ³:å¥äžæ©èœã®è©äŸ¡ãšèšç·Ž(å¿ èŠãªå Žå)
- èªç¥ãªãããªããŒã·ã§ã³:èªç¥æ©èœã®æ¹åãç®æããèšç·Ž
- æ é€ç®¡ç:é©åãªæ 逿åã«ããçèéã®å埩
ð¡ïž æè¡çã®äºé²
æè¡çãå®å šã«äºé²ããããšã¯å°é£ã§ããããªã¹ã¯ãæžããããã«ä»¥äžã®ãããªå¯Ÿçãæå¹ã§ãã
ð ææçã®äºé²
ã¯ã¯ãã³æ¥çš®
以äžã®ã¯ã¯ãã³ã¯ãæè¡çã®åå ãšãªãéçææçãäºé²ããã®ã«æå¹ã§ãã
- èºççèã¯ã¯ãã³:65æ³ä»¥äžãæ ¢æ§çŸæ£ã®ããæ¹ã«æšå¥š
- ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³:æ¯å¹Žã®æ¥çš®ãæšå¥š
- COVID-19ã¯ã¯ãã³:éçåäºé²ã®ããã«æ¥çš®ãæšå¥š
- ç Žå·é¢šãããœã€ã:å€å·æã®æè¡çäºé²
ææŽããšæææ¶æ¯
æãåºæ¬çãã€éèŠãªææäºé²çã§ããæµæ°Žãšç³é¹žã§20ç§ä»¥äžæãæŽãããã¢ã«ã³ãŒã«ç³»æææ¶æ¯è¬ã䜿çšããŸãã
- é£äºã®ååŸ
- ãã€ã¬ã®åŸ
- å€åºããåž°å® ããæ
- å³ããããã¿ã®åŸ
- å·ã®æåœãŠã®ååŸ
åµå·ã±ã¢
å°ããªå·ã§ãé©åã«åŠçœ®ããããšãéèŠã§ãã
- å·å£ãæž æœãªæ°Žã§æŽæµ
- æ¶æ¯è¬ã®é©åãªäœ¿çš
- æž æœãªå 垯ãã¬ãŒãŒã§ä¿è·
- 宿çãªå·å£ã®èгå¯
- ææã®å å(èµ€ã¿ãè «ããç±æãè¿)ãããã°æ©æå蚺
ç®èææçã®äºé²ã«ã€ããŠã¯ãç²ç€ã®äºé²æ³ã¯ããïŒåå ãšåçºãé²ãããã®æ£ããã±ã¢æ¹æ³ã解説ã®èšäºãåèã«ãªããŸãã
ð¥ åºç€çŸæ£ã®ç®¡ç
ç³å°¿ç ã®ç®¡ç
è¡ç³å€ã®ã³ã³ãããŒã«ãäžè¯ã ãšææçã«ãããããããªããŸãã
- 宿çãªè¡ç³å€æž¬å®
- é©åãªè¬ç©çæ³ã®ç¶ç¶
- é£äºçæ³ãšéåçæ³ã®å®è·µ
- 宿çãªå»åž«ã®èšºå¯
æ ¢æ§çŸæ£ã®ç®¡ç
æ ¢æ§è èç ãèçŸæ£ãå¿çŸæ£ãªã©ã®åºç€çŸæ£ãããæ¹ã¯ã宿çãªå»åž«ã®èšºå¯ãåããé©åãªæ²»çãç¶ç¶ããããšãéèŠã§ãã
ðª å ç«åã®ç¶æ
æ é€ãã©ã³ã¹ã®è¯ãé£äº
- ã¿ã³ãã¯è³ªã®ååãªæå
- ãã¿ãã³Cããã¿ãã³Dãäºéãªã©ã®å ç«ã«éèŠãªæ é€çŽ
- çºé µé£åã«ããè žå ç°å¢ã®æ¹å
é©åºŠãªéå
宿çãªéåã¯å ç«æ©èœãåäžãããŸãããã ããé床ãªéåã¯éã«å ç«åãäœäžããããããé©åºŠãªåŒ·åºŠã§ç¶ç¶ããããšãéèŠã§ãã
ååãªç¡ç
ç¡ç äžè¶³ã¯å ç«æ©èœãäœäžãããŸãã1æ¥7~8æéã®è³ªã®è¯ãç¡ç ãå¿ãããŸãããã
ã¹ãã¬ã¹ç®¡ç
æ ¢æ§çãªã¹ãã¬ã¹ã¯å ç«æ©èœãäœäžãããŸãããªã©ã¯ãŒãŒã·ã§ã³æ³ãè¶£å³ã®æéãæã€ãªã©ãã¹ãã¬ã¹è§£æ¶æ³ãèŠã€ããããšã倧åã§ãã
ã¹ãã¬ã¹ç®¡çã«ã€ããŠã¯ãæ¬çªã®ç·åŒµãåãããããæŒãæ³ïœå¹æçãªå Žæãšæ£ããåºæ¿æ¹æ³ã®èšäºã§è©³ãã解説ããŠããŸãã
ð« ãªã¹ã¯è¡åã®åé¿
çŠç
å«ç ã¯èºã®é²åŸ¡æ©èœãäœäžãããåŒåžåšææçã®ãªã¹ã¯ãé«ããŸããçŠç ã¯æè¡çäºé²ã®éèŠãªèŠçŽ ã§ãã
é©åºŠãªé£²é
é床ã®é£²é ã¯å ç«æ©èœãäœäžãããèæ©èœé害ãåŒãèµ·ãããŸããé©éãå®ãããšãéèŠã§ãã
äžé©åãªæèè¬äœ¿çšã®åé¿
æèè¬ã®äžé©åãªäœ¿çšã¯èæ§èã®åºçŸãä¿ããæ²»çå°é£ãªææçã®ãªã¹ã¯ãé«ããŸããå»åž«ã®æç€ºã«åŸã£ãŠé©åã«äœ¿çšããããšãéèŠã§ãã
ðš æè¡çãçãããæã®å¯Ÿå¿
â ïž ç·æ¥å蚺ãå¿ èŠãªçç¶
以äžã®çç¶ãèŠãããå Žåã¯ãæè¡çã®å¯èœæ§ããããããçŽã¡ã«å»çæ©é¢ãå蚺ããŠãã ããã
- é«ç±(38â以äž)ãŸãã¯äœäœæž©(36â以äž)
- æ¿ããæªå¯ãæŠæ
- åŒåžãéããæ¯èŠãã
- æèããããããšããŠãã
- è¡å§ãäœããç«ã¡ããã¿ããã
- å°¿éãèããæžå°ããŠãã
- ç®èãå·ããæ¹¿ã£ãŠãã
- 玫æ(ç®äžåºè¡)ãåºçŸããŠãã
ç¹ã«ä»¥äžã®æ¹ã¯ã軜埮ãªçç¶ã§ãæ©æåèšºãæ€èšããŠãã ãã:
- 65æ³ä»¥äžã®é«éœ¢è
- ç³å°¿ç ãæ ¢æ§è èç ãèçŸæ£ãªã©ã®åºç€çŸæ£ãããæ¹
- å ç«æå¶è¬ãã¹ããã€ãã䜿çšäžã®æ¹
- ããæ²»çäžã®æ¹
- æè¿æè¡ãåããæ¹
ð ææ¥èŠè«ã®å€æ
以äžã®çç¶ãããå Žåã¯ãææ¥è»ãåŒã¶ããšãæ€èšããŠãã ãã:
- æèã¬ãã«ã®èããäœäž
- åŒã³ããã«åå¿ããªã
- åŒåžå°é£ãæ¿ãã
- è¡å§ã枬å®ã§ããªãã»ã©äœã
- å šèº«ã®ç®èãéçœãããŸãã¯çŽ«è²
- ãããããèµ·ãããŠãã
ææ¥èŠè«æã«ã¯ã以äžã®æ å ±ãäŒããŠãã ãã:
- æ£è ã®å¹Žéœ¢ãšæ§å¥
- çŸåšã®çç¶(ãã€ãããã©ã®ãããªçç¶ã)
- åºç€çŸæ£ã®æç¡
- æçšäžã®è¬å€
- æè¿ã®ææçã®æç¡
ð¥ å蚺æã®æºå
å»çæ©é¢ãå蚺ããéã¯ã以äžã®æ å ±ãæŽçããŠãããšèšºæã«åœ¹ç«ã¡ãŸã:
- çç¶ã®çµé(ãã€ãããã©ã®ããã«å€åããã)
- äœæž©ã®èšé²
- æè¿ã®ææçãå€å·ã®æç¡
- åºç€çŸæ£ãšæçšäžã®è¬å€ã®ãªã¹ã
- ã¢ã¬ã«ã®ãŒã®æç¡
- æè¿ã®å»çåŠçœ®(æè¡ãã«ããŒãã«ç眮ãªã©)
ãŸãããè¬æåž³ã蚺å¯åžãæåããããšãéèŠã§ãã
ð¬ æè¡çã®ææ°ç ç©¶ãšæ²»çæ³
𧬠ãã€ãªããŒã«ãŒã®æŽ»çš
è¿å¹Žãæè¡çã®æ©æèšºæãšéç床è©äŸ¡ã®ããã«ãæ§ã ãªãã€ãªããŒã«ãŒã®ç ç©¶ãé²ãã§ããŸãã
ããã«ã«ã·ããã³(PCT)
çŽ°èææçã§ç¹ç°çã«äžæããããŒã«ãŒãšããŠãæè¡çã®æ©æèšºæãšæèè¬æ²»çã®ææšãšããŠæŽ»çšãããŠããŸãããŠã€ã«ã¹ææçã§ã¯äžæãã«ãããããçŽ°èææçãšã®éå¥ã«æçšã§ãã
ãã¬ã»ãã·ã³
ãã¯ããã¡ãŒãžã现èã貪é£ããéã«æŸåºãããç©è³ªã§ãæè¡çã®æ©æèšºæããŒã«ãŒãšããŠæ³šç®ãããŠããŸããããã«ã«ã·ããã³ãããæ©æã«äžæããããšãå ±åãããŠããŸãã
ã€ã³ã¿ãŒãã€ãã³-6(IL-6)
ççæ§ãµã€ãã«ã€ã³ã®äžã€ã§ãæè¡çã®éç床è©äŸ¡ã«çšããããŸãã
ð€ 人工ç¥èœ(AI)ã®æŽ»çš
æ©æ¢°åŠç¿ãAIæè¡ãçšããæè¡çã®æ©æçºèŠã·ã¹ãã ã®éçºãé²ãã§ããŸãã
æ©æèŠåã·ã¹ãã
é»åã«ã«ãã®ããŒã¿ãè§£æããæè¡çã®ãªã¹ã¯ãé«ãæ£è ãèªåçã«æ€åºããã·ã¹ãã ãéçºãããŠããŸãããã€ã¿ã«ãµã€ã³ãæ€æ»å€ãè¬å€äœ¿çšæŽãªã©ã®æ å ±ãç·åçã«åæããå»çã¹ã¿ããã«ã¢ã©ãŒããçºä¿¡ããŸãã
äºåŸäºæž¬ã¢ãã«
AIãçšããŠæè¡çæ£è ã®äºåŸãäºæž¬ããæ²»çæ¹éã®æ±ºå®ã«åœ¹ç«ãŠãç ç©¶ãè¡ãããŠããŸãã
ð æ°ããæ²»çæ³
å ç«èª¿ç¯çæ³
éå°ãªççåå¿ãæå¶ããæ²»çæ³ã®ç ç©¶ãé²ãã§ããŸãã
- ãµã€ãã«ã€ã³é»å®³è¬:IL-1é»å®³è¬ãTNF-αé»å®³è¬ãªã©
- è£äœé»å®³è¬:éå°ãªè£äœæŽ»æ§åãæå¶
- å ç«ã°ãããªã³çæ³:éçäŸã§ã®äœ¿çšãæ€èšãããŠãã
è¡æ¶²æµåçæ³
è¡æ¶²äžã®ççæ§ç©è³ªãçŽ°èæ¯çŽ ãé€å»ããæ²»çæ³ã§ãã
- ãšã³ãããã·ã³åžççæ³:ã°ã©ã é°æ§èã®æ¯çŽ ãé€å»
- ãµã€ãã«ã€ã³åžççæ³:éå°ãªççæ§ç©è³ªãé€å»
- è¡æŒ¿äº€æçæ³:è¡æŒ¿æåã眮æ
å¹¹çŽ°èæ²»ç
éè系幹现èãçšããæè¡çæ²»çã®ç ç©¶ãé²ãã§ããŸãã幹现èã®æççäœçšãçµç¹ä¿®åŸ©äœçšãå©çšããæ²»çæ³ãšããŠæåŸ ãããŠããŸãã
𧪠åå¥åå»ç
éºäŒåæ€æ»
æ£è ã®éºäŒçèæ¯ã調ã¹ãããšã§ãæè¡çã®çºçãªã¹ã¯ãæ²»çåå¿æ§ãäºæž¬ããç ç©¶ãè¡ãããŠããŸãã
è¬çéºäŒåŠ
æ£è ã®éºäŒååã«åºã¥ããŠãæé©ãªæèè¬ã®éžæãæäžéãæ±ºå®ããåå¥åæ²»çã®ç ç©¶ãé²ãã§ããŸãã
ð æè¡çã®ç€ŸäŒç圱é¿
ð ç«åŠããŒã¿
äžçä¿å¥æ©é¢(WHO)ã«ãããšãäžçã§å¹ŽéçŽ4,900äžäººãæè¡çãçºçããçŽ1,100äžäººãæ»äº¡ããŠããŸããããã¯å šæ»äº¡è æ°ã®çŽ20%ã«çžåœããããã«ããæ»äº¡è æ°ãäžåãæ°åã§ãã
æ¥æ¬åœå ã§ã¯:
- 幎éçŽ37äžäººãæè¡çãçºç
- 幎éçŽ10äžäººãæè¡çã§æ»äº¡
- é«éœ¢åã«äŒŽãçºççãå¢å åŸå
- å»çè²»ã¯å¹ŽéçŽ1å åãšæšèš
ð° çµæžçè² æ
æè¡çã¯æ£è ã»å®¶æã ãã§ãªãã瀟äŒå šäœã«å€§ããªçµæžçè² æ ããããããŸãã
çŽæ¥å»çè²»
- éäžæ²»ç宀ã§ã®æ²»çè²»:1æ¥ããã10~20äžå
- 人工åŒåžåšç®¡ç:1æ¥ããã5~10äžå
- è¡æ¶²æµåçæ³:1åããã5~10äžå
- æèè¬æ²»ç:1æ¥ãããæ°åå~æ°äžå
éæ¥è²»çš
- é·æå ¥é¢ã«ããåŽååã®æå€±
- å®¶æã®ä»è·è² æ
- åŸéºçã«ããçæŽ»ã®è³ªã®äœäž
- ãªãããªããŒã·ã§ã³è²»çš
ð¥ å»çã·ã¹ãã ãžã®åœ±é¿
æè¡çæ£è ã®å¢å ã¯ãå»çã·ã¹ãã ã«å€§ããªè² æ ããããŠããŸãã
- éäžæ²»ç宀ã®ãããäžè¶³
- å°éå»çã¹ã¿ããã®äžè¶³
- é«é¡ãªå»çæ©åšã®éèŠå¢å
- æèè¬èæ§èã®å¢å
ð æè²ãšåçºæŽ»å
æè¡çã®èªç¥åºŠåäžã𿩿çºèŠã®ããã«ãæ§ã ãªæè²ã»åçºæŽ»åãè¡ãããŠããŸãã
äžçæè¡çããŒ
æ¯å¹Ž9æ13æ¥ã¯ãäžçæè¡çããŒããšããŠãäžçäžã§æè¡çã®åçºæŽ»åãè¡ãããŠããŸãã
å»çåŸäºè åãæè²
- æè¡çã®æ©æçºèŠã»æ²»çã«é¢ããç ä¿®
- ã¬ã€ãã©ã€ã³ã®æ®å
- ã·ãã¥ã¬ãŒã·ã§ã³èšç·Ž
äžè¬åžæ°åãåçº
- æè¡çã®çç¶ãšå¯ŸåŠæ³ã®åšç¥
- ææäºé²ã®éèŠæ§ã®åçº
- æ©æå蚺ã®ä¿é²
ãããã質å
ææçã¯çްèããŠã€ã«ã¹ãªã©ã®ç åäœãäœå ã«äŸµå ¥ããŠèµ·ããç æ°ã§ãããæè¡çã¯ææçã«å¯Ÿãã身äœã®å ç«åå¿ãéå°ã«ãªããå šèº«ã®èåšã«é害ãäžããç¶æ ã§ããã€ãŸããæè¡çã¯ææçãéçåããç¶æ ãšèããããšãã§ããŸããåãªãææçã§ããã°æèè¬æ²»çã§æ¹åããŸãããæè¡çã§ã¯èåšæ©èœããµããŒãããéäžæ²»çãå¿ èŠã«ãªããŸãã
æè¡çã®åæçç¶ã§æãéèŠãªã®ã¯ãçºç±ïŒ38â以äžïŒãŸãã¯äœäœæž©ïŒ36â以äžïŒãæ¿ããæªå¯ã»æŠæ ãåŒåžãéããªããæèããŒããããããªã©ã§ããç¹ã«é«éœ¢è ã§ã¯å žåçãªçºç±ãèŠãããã飿¬²äžæ¯ãæŽ»åæ§ã®äœäžãæ¥ãªèªç¥æ©èœã®å€åãªã©ãåæãµã€ã³ãšãªãããšããããŸãããããã®çç¶ãè€æ°çµã¿åããã£ãŠçŸããå Žåã¯ãéããã«å»çæ©é¢ãå蚺ããããšãéèŠã§ãã
æè¡çã¯æ©æçºèŠã»æ©ææ²»çã«ãã宿²»å¯èœãªçŸæ£ã§ããããããéçåºŠãæ²»çéå§ã®ã¿ã€ãã³ã°ã«ãã£ãŠäºåŸã¯å€§ããç°ãªããŸãã軜çã®æè¡çã§ã¯å®å šå埩ãæåŸ ã§ããŸãããæè¡çæ§ã·ã§ãã¯ãå€èåšäžå šãèµ·ãããå Žåã¯ãæ ¢æ§ç²åŽãçåäœäžãèªç¥æ©èœé害ãPTSDããã€ç ãªã©ã®é·æçãªåŸéºçïŒPost-Sepsis SyndromeïŒãæ®ãããšããããŸããé©åãªãªãããªããŒã·ã§ã³ã«ããããããã®åŸéºçã®æ¹åãæåŸ ã§ããŸãã
æè¡çã®æ²»çæéã¯éç床ã«ãã倧ããç°ãªããŸãã軜çã®å Žåã¯1-2é±éçšåºŠã®å ¥é¢æ²»çã§æ¹åããããšãå€ãã§ãããæè¡çæ§ã·ã§ãã¯ãå€èåšäžå šã䌎ãéçäŸã§ã¯æ°é±éããæ°ã¶æã®éäžæ²»çãå¿ èŠã«ãªãããšããããŸããæèè¬æ²»çã¯éåžž7-14æ¥éç¶ç¶ãããŸãããæææºãåå èã«ãã£ãŠèª¿æŽãããŸããéé¢åŸããªãããªããŒã·ã§ã³ã倿¥ã§ã®çµé芳å¯ãæ°ã¶æéå¿ èŠã«ãªãå ŽåããããŸãã
æè¡çã®äºé²ã§æãéèŠãªã®ã¯åºæ¬çãªææäºé²çã®åŸ¹åºã§ããææŽããšæææ¶æ¯ãé©åã«è¡ããã¯ã¯ãã³æ¥çš®ïŒèºççèãã€ã³ãã«ãšã³ã¶ãCOVID-19ãªã©ïŒãåãããå°ããªå·ã§ãé©åã«åŠçœ®ãããåºç€çŸæ£ïŒç³å°¿ç ãªã©ïŒã®ç®¡çãè¡ãããšãéèŠã§ãããŸããå ç«åãç¶æããããã«ããã©ã³ã¹ã®è¯ãé£äºãé©åºŠãªéåãååãªç¡ç ãã¹ãã¬ã¹ç®¡çãå¿ãããããšã倧åã§ããé«éœ¢è ãåºç€çŸæ£ã®ããæ¹ã¯ã軜埮ãªçç¶ã§ãæ©æã«å»çæ©é¢ãå蚺ããããšãæšå¥šãããŸãã
ð¥ ãŸãšã
æè¡çã¯ãææçã«å¯Ÿãã身äœã®éå°ãªå ç«åå¿ã«ãããå šèº«ã®èåšæ©èœãé害ãããé節ãªçŸæ£ã§ãã幎éçŽ37äžäººãçºçããçŽ10äžäººãåœãèœãšããšãããæ±ºããŠçšã§ã¯ãªãçŸæ£ã§ããããšãçè§£ããŠããã ããã§ããããã
æ¬èšäºã§è§£èª¬ããéèŠãªãã€ã³ãããŸãšãããšïŒ
- æ©æçºèŠãçæ»ãåããïŒçºç±ãæªå¯ãåŒåžå°é£ãæèé害ãªã©ã®çç¶ãèŠéããªã
- æéãšã®æŠãïŒçç¶åºçŸãã1æé以å ã®æ²»çéå§ãçåçã倧ããå·Šå³ãã
- äºé²ãæãéèŠïŒææŽããã¯ã¯ãã³æ¥çš®ãåºç€çŸæ£ã®ç®¡çãå ç«åã®ç¶æ
- é«éœ¢è ã¯ç¹ã«æ³šæïŒå žåçãªçç¶ãçŸãã«ããã軜埮ãªå€åãæè¡çã®ãµã€ã³ã®å¯èœæ§
- é·æçãªãã©ããŒãå¿ èŠïŒå埩åŸãåŸéºçãåçºã®ãªã¹ã¯ããã
æè¡çã¯å»åŠã®é²æ©ã«ããæ²»çæçžŸã¯æ¹åããŠããŸãããäŸç¶ãšããŠæ»äº¡çã®é«ãçŸæ£ã§ããããããæ£ããç¥èãæã¡ãé©åãªäºé²çãå®è·µããçç¶ãæ©æã«çºèŠããŠè¿ éã«å¯Ÿå¿ããããšã§ãå€ãã®åœãæãããšãã§ããŸãã
ç¹ã«åºç€çŸæ£ããæã¡ã®æ¹ãé«éœ¢è ã®æ¹ãå ç«åãäœäžããŠããæ¹ã¯ãæ¥é ããææäºé²ãå¿ãããäœèª¿ã®å€åã«æ³šæãæãããšãéèŠã§ãããŸããåšå²ã®æ¹ã ãæè¡çã®çç¶ã«ã€ããŠçè§£ããå¿ èŠãªæã«ã¯è¿ éãªå蚺ãä¿ãããšã倧åã§ãã
å»çæè¡ã®çºå±ã«ãããAIãæŽ»çšããæ©æèšºæã·ã¹ãã ãæ°ããæ²»çæ³ã®ç ç©¶ãé²ãã§ããŸããä»åŸãæè¡çã®äºåŸã¯ããã«æ¹åããŠããããšãæåŸ ãããŸãããçŸåšã«ãããŠãæ©æçºèŠã»æ©ææ²»çã®éèŠæ§ã¯å€ãããŸããã
ãã®èšäºããæè¡çã«å¯Ÿããçè§£ãæ·±ããé©åãªäºé²ãšå¯Ÿå¿ã«ã€ãªããããšãé¡ã£ãŠããŸããæ°ã«ãªãçç¶ãããå Žåã¯ãèºèºããã«å»çæ©é¢ãå蚺ããŠãã ããã
ð åèæç®
- åçåŽåç – ææç察çã»å»çå®å šå¯Ÿç
- åœç«ææçç ç©¶æ – ææçç«åŠã»ã³ã¿ãŒ
- æ¥æ¬éäžæ²»çå»åŠäŒ – æè¡ç蚺çã¬ã€ãã©ã€ã³2020
- æ¥æ¬ææ¥å»åŠäŒ – ææ¥å»çã«ãããææç察ç
- Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
ç£ä¿®è å»åž«
髿¡ã康倪 å»åž«
ä¿æè³æ Œ
ãã©ãã©ã€èªå®å»
ç¥æŽ
- 2009å¹Žãæ±äº¬å€§åŠå»åŠéšå»åŠç§åæ¥
- 2009å¹Žãæ±äº¬éä¿¡ç é¢å€å
- 2012å¹Žãæ±äº¬èŠå¯ç é¢å€å
- 2012å¹Žãæ±äº¬å€§åŠå»åŠéšéå±ç é¢å€å
- 2019幎ãåœé¢æ²»ç責任è 就任
- ç®èè «çã»ç®èå€ç§é åã§15幎以äžã®èšåºçµéšãš30,000ä»¶è¶ ã®æè¡å®çžŸãæã¡ãå»åŠçæ ¹æ ã«åºã¥ãç£ä¿®ãæ åœ
- å°éåéïŒç®èè «çãç®èå€ç§ãç®èç§ã圢æå€ç§
- èšåºå®çžŸïŒ2024幎æç¹ïŒ ç®èè «çã»ç®èå€ç§æè¡ïŒ30,000件以äžãè èçæ²»çïŒ2,000件以äžãé ãã»èµ€ã顿²»çïŒ1,000件以äž
- ç£ä¿®é å ç®èè «çïŒã»ããã»ç²ç€ã»èèªè «ãªã©ïŒãç®èå€ç§æè¡ãç®èãããäžè¬å»çã³ã©ã ã«é¢ããå»çæ å ±
äœè€ãææš¹ å»åž«
ä¿æè³æ Œ
æ¥æ¬æŽåœ¢å€ç§åŠäŒæŽåœ¢å€ç§å°éå»
ç¥æŽ
- 2010幎ãçæ³¢å€§åŠå»åŠå°éåŠçŸ€å»åŠé¡åæ¥
- 2012å¹Žãæ±äº¬å€§åŠå»åŠéšä»å±ç é¢å€å
- 2012å¹Žãæ±äº¬éä¿¡ç é¢å€å
- 2013幎ãç¬ç«è¡æ¿æ³äººåŽåè å¥åº·å®å 𿩿§ 暪æµåŽçœç é¢å€å
- 2015幎ãåœç«ç ç©¶éçºæ³äºº åœç«åœéå»çç ç©¶ã»ã³ã¿ãŒç é¢å€åãçµãŠåœé¢å€å
æè¡çã®èšºæã«ãããŠéèŠãªã®ã¯ããããã®ã¹ã³ã¢ã«é Œãããããæ£è æ§ã®å šèº«ç¶æ ãç·åçã«è©äŸ¡ããããšã§ããç¹ã«é«éœ¢è ã§ã¯ãå žåçãªçç¶ãçŸãã«ãããè»œåŸ®ãªæèã¬ãã«ã®å€åãé£æäžæ¯ãªã©ãæè¡çã®åæãµã€ã³ã§ããããšããããŸããåœé¢ã§ã¯ããããã®åŸ®çްãªå€åãèŠéããªããããäžå¯§ãªèšºå¯ãšè¿ éãªæ€æ»ãå¿ãããŠããŸãã